Clàudia Fortuny Guasch
Investigador
Research group
Last Publications
- Pons-Tomàs G, Irene Martínez de Albéniz, Rios-Barnés M, Gamell Fullà A, Simó-Nebot S, Balsells S, Hernández-García M, Melé-Casas M, Sánchez E, Manuel Monsonis Cabedo, Gene-Giralt A, López M, Salvia D, García-García JJ, Fortuny-Guasch C and Fumadó V Serological Outcome in the First Months of Life of Children Born to Mothers with SARS-CoV-2 Infection during Pregnancy. CHILDREN-BASEL . 11(9): .
- Pons-Tomas, Gemma, Hernandez-Garcia, Maria, Mele-Casas, Maria, Fernández de Sevilla-Estrach M, Launes-Montana C, Girona M, Rios-Barnés M, Bassat Q, Ajanovic, Sara, Cubells M, Claverol J, Penela-Sanchez, Daniel, Jou-Munoz C, Manuel Monsonis Cabedo, Esteva-Afonso C, Fassanella, Assumpta, Cuadras-Palleja D, Munoz-Almagro C, Jordán-García I, Fortuny-Guasch C, García-García JJ and Fumadó V Clinical Characterization, Transmissibility, and Seroconversion of SARS-CoV-2 Infection in Children (before the Start of Vaccination) in the Barcelona Metropolitan Region (Spain) Journal of Pediatric Infectious Diseases . 19(05): 251-259.
- Gamell Fullà A, Velasco E, López-Ramos MG, Rios-Barnés M, Simó-Nebot S, Fumadó V, Noguera-Julián A and Fortuny-Guasch C Off-label use of dalbavancin in children: a case series. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 79(8): 2062-2067.
Projects
- Project name:
- SGR 2022-2024_Enfermedades Infecciosas en la Edad Pediátrica y Microbioma
- Leader
- Carmen Muñoz Almagro
- Funding entities:
- Agaur - Agència de Gestió d'Ajuts Universitaris i de Recerca
- Code
- 2021 SGR 00396
- Starting - finishing date:
- 2022 - 2025
- Project name:
- Science4Pandemics: Cizitens engagement digital platform for collective intelligence in pandemics
- Leader
- Begoña Nafria Escalera
- Funding entities:
- Fundació Privada per a la Recerca i la Docència Sant Joan de Déu - FSJD, EIT Health e.V
- Code
- 220365
- Starting - finishing date:
- 2022 - 2024
- Project name:
- Estudio de la toxicidad mitocondrial en recien nacidos y lactantes con infección congénita por citomegalovirus tratados con ganciclovir o valganciclovir
- Leader
- Clàudia Fortuny Guasch
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- PI17/00359
- Starting - finishing date:
- 2018 - 2022
News
-
Measuring antibodies in saliva is a useful and easy strategy to detect SARS-CoV-2 infections
A study, published in BMC Medicine, performed through the Kids Corona platform from Sant Joan de Déu in collaboration with ISGlobal, shows that measuring antibodies in saliva is a useful and easy strategy to detect SARS-CoV-2 infections.